Laboratorios Farmaceuticos Rovi, S.A. Profit Margin

As of the most recent data (June 2026), ROVI.MC shows a profit margin of 23.95%. That compares with 17.66% in the prior-year period — up 35.6% year over year. That is above the sector sector average of 13.09%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ROVI.MC's profit margin is now 23.95% (was 17.66%) — a 35.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Laboratorios Farmaceuticos Rovi, S.A. is outperforming or lagging.

The its sector sector average profit margin is about 13.09%. Laboratorios Farmaceuticos Rovi, S.A. is at 23.95%, which is higher that average. That is roughly 83.0% above the sector mean. Use the comparison chart on this page to see how ROVI.MC stacks up against individual peers as well.

That compares with 17.66% in the prior-year period — up 35.6% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Laboratorios Farmaceuticos Rovi, S.A. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Laboratorios Farmaceuticos Rovi, S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 23.95%) with ownership activity and broader fundamentals.